Boomer S, Eiden M, Burns C C, Overbaugh J
University of Washington, Seattle 98195, USA.
J Virol. 1997 Nov;71(11):8116-23. doi: 10.1128/JVI.71.11.8116-8123.1997.
Subgroup B feline leukemia viruses (FeLV-Bs) evolve from subgroup A FeLV (FeLV-A) by recombining with portions of endogenous FeLV envelope sequences in the cat genome. The replication properties of FeLV-B are distinct from those of FeLV-A; FeLV-B infects many nonfeline cell lines and recognizes the human Pit1 (HuPit1) receptor, whereas FeLV-A infects primarily feline cells, using a distinct but as yet undefined receptor. Here, we demonstrate that some FeLV-Bs can also use human Pit2 (HuPit2) and hamster Pit2 (HaPit2) for entry. By making viruses that contain chimeric surface (SU) envelope proteins from FeLV-A and FeLV-B, and testing their infectivity, we have defined genetic determinants that confer host range and specific receptor recognition. HuPit1 receptor recognition determinants localize to the N-terminal region of the FeLV-B SU, amino acids 83 to 116, encompassing the N-terminal portion of variable region A (VRA). While this 34-amino-acid domain of the FeLV-B VRA is sufficient for infection of some cells (feline, canine, and human), amino acids 146 to 249 of FeLV-B, which include variable region B (VRB), were required for efficient infection in other cell types (hamster, bovine, and rat). Chimeras encoding FeLV-B VRA and VRB also infected cells expressing HaPit2 and HuPit2 receptors more efficiently than chimeras encoding only the VRA of FeLV-B, suggesting that VRB provides a secondary determinant that is both cell and receptor specific. However, viruses containing additional FeLV-B sequences in the C terminus of SU could not recognize HuPit2, implying that there is a determinant beyond VRB that negatively affects HuPit2 interactions. Thus, Pit2 recognition may drive selection for the generation of specific FeLV-B recombinants, offering an explanation for the two major classes of FeLV-B that have been observed in vivo. Furthermore, the finding that some FeLV-Bs can use both Pit1 and Pit2 may explain previous observations that FeLV-B and GALV, which primarily uses Pit1, display nonreciprocal interference on many cell types.
B亚群猫白血病病毒(FeLV-B)是通过与猫基因组中的内源性FeLV包膜序列部分重组,从A亚群FeLV(FeLV-A)进化而来。FeLV-B的复制特性与FeLV-A不同;FeLV-B可感染许多非猫科细胞系,并识别人类Pit1(HuPit1)受体,而FeLV-A主要感染猫科细胞,使用一种独特但尚未明确的受体。在此,我们证明一些FeLV-B也可利用人类Pit2(HuPit2)和仓鼠Pit2(HaPit2)进入细胞。通过构建含有来自FeLV-A和FeLV-B的嵌合表面(SU)包膜蛋白的病毒,并测试它们的感染性,我们确定了赋予宿主范围和特定受体识别能力的遗传决定因素。HuPit1受体识别决定因素定位于FeLV-B SU的N端区域,即氨基酸83至116,涵盖可变区A(VRA)的N端部分。虽然FeLV-B VRA的这个34个氨基酸的结构域足以感染某些细胞(猫科、犬科和人类),但FeLV-B的氨基酸146至249(包括可变区B(VRB))是在其他细胞类型(仓鼠、牛和大鼠)中高效感染所必需的。编码FeLV-B VRA和VRB的嵌合体也比仅编码FeLV-B VRA的嵌合体更有效地感染表达HaPit2和HuPit2受体的细胞,这表明VRB提供了一个细胞和受体特异性的二级决定因素。然而,在SU的C端含有额外FeLV-B序列的病毒无法识别HuPit2,这意味着在VRB之外存在一个对HuPit2相互作用产生负面影响的决定因素。因此,Pit2识别可能驱动特定FeLV-B重组体产生的选择,为体内观察到的两类主要FeLV-B提供了解释。此外,一些FeLV-B可以同时使用Pit1和Pit2这一发现,可能解释了先前的观察结果,即主要使用Pit1的FeLV-B和GALV在许多细胞类型上表现出非相互干扰。